PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost
PFS & Injectable drug devices Europe
AI in Drug Discovery
Bio Trinity
Anglo Nordic
Genesis 13.11.25
BioPharma 23.10.25

Advertisement

A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
Light Cast – 17.07.2025
QMB Innovation Centre

Aurisco

Established in 1998, Aurisco is an innovative pharmaceutical company engaged in research, development, manufacturing and marketing of specialty APIs, formulations as well as CRDMO service. With 6 R&D centers and opening its 4th cGMP manufacturing site, the company has offices in USA, Portugal, China, India and Brazil. Aurisco has been deeply involved in the pharmaceutical industry for more than 26 years and commits itself to continuous technological innovation and sustainability. Having passed 5 cGMP inspections in 2023 (USFDA/EUGMP/PMDA/NMPA/KFDA), Aurisco Pharmaceutical is expanding with new workshops for peptides (Semaglutide, Tirzepatide) and Oligonucleotides (New oligoprocess flexfactory for ASOs and siRNAs) and a new manufacturing site in 2025, growing its toolbox of technologies, small molecule API offer and unbeatable CRDMO services for oligonucleotides and peptides. Today, the company plays a leading role in China and global markets in the field of complex synthesis, synthetic biology, photochemistry and continuous flow chemistry. Aurisco is Ecovadis Gold ranked and joined the SBTi with a target of becoming carbon neutral by 2027, reaching zero emissions by 2030, being a reliable long-term partner of the well-known pharmaceutical companies worldwide. Our focus on customer service, mature quality system, regulatory experience, growing production capacity and global sales network enables the company to provide high-quality products and efficient service to our customers around the world.

Commercial APIs API Name DMFDrug Mater File
Abiraterone AcetateEU,US,CANADA,CHINA,JAPAN, BRAZIL 
ApalutamideUS, CHINA
Bempedoic AcidEU, US, CHINA
Betamethasone ValerateEU(CEP), CANADA
BrivaracetamEU, US, CANADA, CHINA
Elagolix EU, US  
EnzalutamideEU, US, CHINA
Eplerenone EU(CEP), US, CANADA, JAPAN
Finerenone US, EU
DydrogesteroneEU(CEP), US, CHINA
Fluticasone PropionateEU(CEP), US, CHINA
Fluticasone FuroateEU(CEP), US, CHINA
Mometasone FuroateEU(CEP), US
Nusinersen (ASO, Oligonucleotides)DMF Ready
Pregabalin EU(CEP), US, CANADA, CHINA 
Relugolix US
SemaglutideUS
TDF (Tenofovir Disoproxil Fumarate)EU, US, CHINA
TAF (Tenofovir Alafenamide Hemifumarate)EU, US, CHINA
TMF(Tenofovir Alafenamide Monofumarate)EU, US, CHINA
Vibegron US
Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Polypure hompage